Cita APA (7a ed.)

Simon, D., Tascilar, K., Krönke, G., Kleyer, A., Zaiss, M. M., Heppt, F., . . . Schett, G. (2020). Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nature Portfolio.

Cita Chicago Style (17a ed.)

Simon, David, et al. Patients with Immune-mediated Inflammatory Diseases Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Seroconversion. Nature Portfolio, 2020.

Cita MLA (8a ed.)

Simon, David, et al. Patients with Immune-mediated Inflammatory Diseases Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Seroconversion. Nature Portfolio, 2020.